secwatch.observer — SEC 8-K summary
======================================

Issuer:     CG Oncology, Inc. (CGON)
CIK:        0001991792
Form:       8-K
Filed at:   2026-01-13T23:59:59+00:00
Accession:  0001193125-26-011855
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CG Oncology ups ATM equity offering capacity by $300M to $550M
--------------------------------------------------------------

- Filing increases aggregate offering of common stock under Open Market Sale Agreement from $250M to $550M.
- Previously sold 5,861,984 shares for gross proceeds of $250M under the agreement.
- Amendment adds $300M in unregistered shares available for sale through Jefferies LLC.
- Proceeds from future sales will be used for general corporate purposes as per prior prospectus.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1991792/000119312526011855/0001193125-26-011855-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1991792/000119312526011855/d907258d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-011855

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer